UK NHS Insights

The Changing NHS Environment for UK Market Access

The changing NHS environment brings unique challenges for UK market access. To ensure our Pharma and Medtech clients are always one step ahead, we strive to be as close as possible to the NHS.

To achieve this goal, we have an in-house team who specialise in NHS insights and UK market access, with experience working in the NHS, in UK market access and in industry.

We have also contracted with over 90+ associates who currently hold roles across the NHS, from CEO to HCA, as well as an increasing range on non-traditional and non-NHS roles.

Our unique NHS relationships guide and validate everything we do in the UK.

For your UK market access strategy to be successful, it is essential that you understand your customers. We provide unparalleled depth of insight into all areas of the NHS, from national policy through commissioning strategy to challenges on the front line of care delivery.

Our expert teams use these insights to inform, develop and validate HEOR strategies, health economic modelling, HTA submissions,  customer communication materials and engaging digital communication aids.

How can NHS insights enhance your UK market access journey?

We partner with you to unlock opportunities and implement impactful market access campaigns.

We can apply insights directly into our UK market access projects or support you with specific education or insight sessions:

To discuss your UK market access strategy with our experts or to learn more about our NHS education and insights services, get in touch using the form below.

    Keep me up to date with the latest news and events.

    UK strategy and materials:

    Education:

    • Bespoke updates on NHS policies and strategy relevant to your area of interest
    • Continuing development of understanding through led educational programmes
    • Dispelling myths and preconceptions about the NHS
    • Bridging the gap between policy and theory, and how care is actually delivered
    • Enhancing skills and techniques for engaging with the NHS

    Insight:

    • Engaging interested and thoughtful colleagues from within the NHS
    • Validation of strategic principles and messaging with NHS stakeholders
    • Interrogation and evaluation of product strategy and approach
    • Facilitation of meetings, with and without HCPs, to achieve a range of objectives
    • Broader strategic and tactical development
    • Deep Insights

    To discuss your UK market access strategy with our experts or to learn more about our NHS education and insights services, get in touch using the form below.

      Keep me up to date with the latest news and events.

      Why choose Mtech Access?

      90
      NHS Associates
      80
      years' NHS experience
      65
      clients
      • We draw insights from a network of over 90 Associates currently working in NHS roles across the UK, covering 32 of the 42 integrated care systems in England, as well as Scotland and Wales
      • Our network includes relationships with 3 Academic Health Science Networks (AHSNs)
      • At Mtech Access, we have conducted 200+ NHS insights and education projects with 65+ clients*
      • Our NHS Insight & Interaction team collectively have over 80 years’ experience in working in NHS and healthcare settings†
      • Our knowledge of the NHS is utilised across all our UK-based projects

      *Includes any distinct project for an external Pharmaceutical, Medtech, Biotech, Diagnostics or Healthcare client.

      †Includes senior team members’ experience prior to joining Mtech Access.

      “I was impressed by the calibre of the Associates in your network. It means that we had the perfect experts to provide input on our UK market access strategy. The advisory board was well structured and engaging – 5/5 for facilitation! We have already made a start on the recommendations, and these have really helped us prioritise the different activities and shaped our thinking.”

      Pricing, Reimbursement & Access ManagerTop 20 Pharma Company

      “Thank you Mtech Access for organising such a collaborative and interesting event, in the Cancer Alliances Above Brand event. Following the workshop sessions, I am really interested in continuing our engagement with the Cancer Alliances.”

      Healthcare Account ManagerAmazon Web Services

      “The UK Diagnostic Landscape Study has proved to be really good value for money – we’re really pleased. The report has provided our UK team with a lot more detail than we had before, and we are taking learnings forward to apply to our European strategy.”

      Market Access and HEOR DirectorDiagnostics and Medical Device company

      “Mtech Access is the best consultancy, in my opinion, due to the calibre of the people. The team were really easy to work with, were quick to action everything, and kept us updated on the whole process”

      Senior Market Access and Reimbursement ManagerMedtech Company

      “The NHS update training session was pitched right so as to resonate with both our market access and clinical teams. We were really interested to find out about the new procurement processes that are being introduced in the NHS and the new Integrated Care System (ICS) structure. The team have already begun leveraging what we learned during the session to approach the right stakeholders with messages focused on quality of life impact.”

      UK Head of Market AccessWound Care Company

      “I was really pleased with how the advisory board went. The outcomes were good and useful. If you are looking for something slightly different, go to Mtech. [When working with Mtech, ] we know we’re going to get what’s promised and that there will always be delegates with interesting roles who have a real desire to engage in the process.”

      Market Access ManagerTop 20 pharma company

      "Mtech Access are spot on with their real NHS knowledge and it is always up to date. They are always able to align what’s going on within the NHS with our commercial objectives."

      Market Access DirectorPharma

      "What Mtech Access do is unique. They have a set of people with varied and experienced roles who can translate between the NHS and industry and offer industry real time feedback.”

      Market Access ManagerTop 20 Pharma company

      “We have definitely seen benefits from the NHS update sessions. Whilst my team have a strong understanding of the NHS, we want to stay on top of what’s happening. These sessions are useful because we can test our ideas. The insights gained have helped us build value propositions which are well received and accepted.”

      Commercial Director Top 20 Medical Devices company

      “The mock meeting was excellent and very well delivered. The team were so responsive, easy to communicate with, very flexible and able to implement things last minute. We would definitely do this again with Mtech!”

      HTA & Access Leadtop 20 pharma company
      • We draw insights from a network of over 80 Associates currently working in NHS roles across the UK, covering 32 of the 42 integrated care systems in England, as well as Scotland and Wales
      • Our network includes relationships with 3 Academic Health Science Networks (AHSNs)
      • At Mtech Access, we have conducted 135+ NHS insights and education projects with 40+ clients*
      • Our NHS Insights & Interaction team collectively have over 100 years’ experience in working in NHS and healthcare settings†
      • 8 team members have experience working in the NHS
      • 5 team members currently hold executive, non-executive, or advisory roles in the NHS
      • We have access to data and information that other consultancies don’t
      • Our knowledge of the NHS is utilised across all our UK-based projects

      *Includes any distinct project for an external Pharmaceutical, Medtech, Biotech, Diagnostics or Healthcare client.

      †Includes senior team members’ experience prior to joining Mtech Access.

      Understanding the evolving NHS

      We can help you answer key questions related to the changing NHS. Contact us today to explore these questions and what they mean for your UK market access strategy with our team:

      • How do we communicate with Integrated Care Systems (ICS), Places and Primary Care Networks (PCNs)?
      • Who should we talk to in the NHS and what do they need to know?
      • How do we get in front of ICS leads?
      • How do we capture pathways of care?
      • What are the threats and opportunities for our products?
      • How do we move away from product-led conversations?
      • Should we be having portfolio-level conversations with NHS leaders?
      • Do we still need a value proposition and budget impact model to engage with the NHS?

      Understanding the evolving NHS

      We can help you answer key questions related to the changing NHS. Contact us today to explore these questions and what they mean for your UK market access strategy with our team:

      • How do we communicate with Integrated Care Systems (ICS), Places and Primary Care Networks (PCNs)?
      • Who should we talk to in the NHS and what do they need to know?
      • How do we get in front of ICS leads?
      • How do we capture pathways of care?
      • What are the threats and opportunities for our products?
      • How do we move away from product-led conversations?
      • Should we be having portfolio-level conversations with NHS leaders?
      • Do we still need a value proposition and budget impact model to engage with the NHS?

      UK Market Access and NHS Customer Engagement

      Are you ready to drive change in UK healthcare? Discover how we can support your UK Market Access strategy.

      Download Brochure
      UK Market Access flyer - download

      NHS Whispers webinar and podcast series

      We interview leaders from across the NHS about the changing NHS environment. From integrated care to population health to policy and innovation… the series explores the current challenges and trends facing the NHS:

      NHS and UK market access articles

      Maximising NHS impact on a budget

      Maximising NHS impact on a budget: assessing value in healthcare

      In this live lecture, Hannah Baker (Consultant – Health Economics) outlines the role health economics plays in modern healthcare…

      So, what is happening with specialised commissioning in the NHS? cover

      So, what is happening with specialised commissioning in the NHS?

      Specialised Commissioning continues to be an issue of significance and uncertainty for both industry and the NHS. What do the latest reports of regional push back on the plans for devolution to ICBs mean?…

      How the life sciences industry can bring meaningful change to the NHS cover

      How the life sciences industry can bring meaningful change to the NHS

      How can the life sciences industry and the NHS work together to deliver real change? An overview of the key themes from our 2023 NHS Transformation Symposium…